Thyrotropin-releasing hormone (TRH) is an endogenous tripeptide that acts as a neurotransmitter and neurohormone. TRH regulates hypothalamic-pituitary-adrenal (HPA) and estrogenic signaling pathways. TRH exhibits immunomodulatory and neuroprotective activities. TRH prevents oxidative stress, caspase-mediated apoptosis, glutamate toxicity, and neuroinflammation. Additionally, TRH stimulates epidermal regeneration in ex vivo models, increasing would healing. TRH activates the TRH receptor.
CAT No: R1836
CAS No:24769-58-2
Synonyms/Alias:24769-58-2;L-Proline, 5-oxo-L-prolyl-L-histidyl-;Trh-OH;TRH (free acid);PGlu-3-methyl-His-Pro-NH2;D-His-Protirelin;Acid-TRH;pGlu-His-Pro amide;MFCD00038638;L-Proline,5-oxo-L-prolyl-L-histidyl-;A-42872;SCHEMBL9474691;CHEMBL3904583;HY-P1529;MS-25778;CS-0044793;(2S)-1-[(2S)-3-(1H-IMIDAZOL-4-YL)-2-{[(2S)-5-OXOPYRROLIDIN-2-YL]FORMAMIDO}PROPANOYL]PYRROLIDINE-2-CARBOXYLIC ACID;(2S)-1-[(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carboxylic acid;(S)-1-((S)-3-(1H-imidazol-4-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanoyl)pyrrolidine-2-carboxylic acid;
Thyrotropin-Releasing Hormone (TRH), Free Acid is a tripeptide neurohormone composed of pyroglutamyl-histidyl-proline, recognized for its pivotal role in the regulation of the hypothalamic-pituitary-thyroid (HPT) axis. As an endogenous peptide, TRH is produced in the hypothalamus and transported to the anterior pituitary, where it stimulates the secretion of thyroid-stimulating hormone (TSH). Its concise structure, high evolutionary conservation, and central involvement in neuroendocrine signaling make it a valuable molecular tool for probing peptide function, receptor-ligand interactions, and signal transduction pathways. Due to its well-characterized activity and defined sequence, TRH is widely utilized in biochemical research focused on neuropeptide dynamics, endocrine feedback mechanisms, and peptide-based drug discovery.
Neuroendocrine Regulation Studies: TRH, Free Acid is extensively employed in research exploring the molecular mechanisms governing neuroendocrine signaling. Its ability to precisely activate TRH receptors in pituitary and extrapituitary tissues enables detailed investigation of hormone release dynamics, receptor desensitization, and downstream signaling cascades. By applying this tripeptide to in vitro cell models or ex vivo tissue preparations, researchers can dissect the regulatory loops that control TSH secretion, elucidate the cross-talk between neuropeptide systems, and characterize the molecular determinants of hypothalamic-pituitary communication.
Receptor-Ligand Interaction Analysis: In the context of receptor pharmacology, TRH serves as a prototypical ligand for G protein-coupled receptors (GPCRs) of the TRH receptor subtype. Its defined sequence and high receptor affinity make it an ideal tool for binding assays, structure-activity relationship (SAR) studies, and the screening of novel receptor modulators. Utilizing radiolabeled or fluorescently tagged forms, scientists can quantify binding kinetics, assess receptor specificity, and evaluate the functional consequences of receptor activation or inhibition, thereby advancing the understanding of peptide-GPCR interactions.
Peptide Synthesis and Analytical Method Development: As a well-characterized tripeptide, TRH is frequently used as a reference standard or calibration compound in peptide synthesis workflows and analytical method development. Its physicochemical properties support the optimization of chromatographic techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS) for peptide identification, quantification, and purity assessment. Incorporating TRH as a benchmark facilitates the validation of synthetic protocols and the refinement of analytical platforms for broader peptide research applications.
Neuropeptide Signaling Pathway Elucidation: TRH, Free Acid is a valuable probe for delineating neuropeptide signaling networks beyond the classical HPT axis. Experimental application in neuronal cultures and brain slice preparations allows researchers to map the distribution of TRH-responsive cells, monitor intracellular signaling events, and investigate the modulatory effects of TRH on neurotransmitter release. Such studies contribute to a deeper understanding of how neuropeptides integrate with synaptic transmission and influence central nervous system function.
Peptidase Activity Assays: Due to its susceptibility to enzymatic degradation by specific peptidases, TRH is utilized in assays designed to characterize peptide-cleaving enzymes. By monitoring the hydrolysis of TRH under controlled experimental conditions, scientists can evaluate peptidase substrate specificity, inhibitor efficacy, and the kinetics of peptide turnover. These investigations support the discovery of novel enzyme inhibitors and enhance knowledge of peptide metabolism within physiological and pathological contexts.
3. Emu oil in combination with other active ingredients for treating skin imperfections
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More